The new
SB 535 law in Montana (
background) creates the first-ever scalable business model to administer therapies under
right-to-try laws.
We are a
coalition of individuals & groups with connections in
biotech, academia, venture capital and (local) medical clinics, looking to fund and assist partners seeking to enter Montana under SB 535 under the working title "Montana Longevity Coalition".
About This Questionnaire
This form has two parts:
Part 1: Indicate Partner Interest
Part 2: Request for Proposals
You should fill out Part 1 if you:
- Represent one or more of: Clinics, MDs, biotechs, manufacturers, CROs, pharma companies, individual professionals with a strong track record in your area of expertise.
You should fill out Part 2 if you:
- Have or are working on biopharma assets/IP and:
- Aim to treat patients at scale using treatments that are not approved by the FDA, but are at a minimum proven to be safe and at best come with a high degree of scientific evidence of their efficacy (e.g. already approved in other countries like Japan, Europe etc.)
- Have a focus broadly on longevity, regenerative, preventative or precision medicine - treatment of diseases or terminal illness is not necessarily in contrast, please apply anyway
- Have interest in pursuing faster alternatives to the conventional drug development pathway, in alignment with the ideas around R2T of medical freedom. For example by working through US pathways like state R2T, compassionate use, or non-US jurisdictions
Next Step
Partners that are a fit with the program will be invited to take part in small circle info sessions on the details of how to enter Montana under SB 535.
Data Privacy Statement
Your privacy is important to us. The information you provide in this questionnaire will be used solely for the purpose of evaluating potential participation in the Montana Longevity Coalition and related research or business development activities. All responses will be treated as confidential and will only be accessible to authorized members of the coalition’s research and operations team. We will not share your personally identifiable information or proprietary business details with third parties without your explicit consent, except as required by law. Data may be aggregated and anonymized for reporting or analysis, but no individual or company will be identified in any public materials without prior written permission. By submitting this questionnaire, you acknowledge and consent to the collection and use of your information as described above. If you have any questions about how your data will be used or wish to request deletion of your information, please contact us at [email protected]